Akorn Vaccine Deal Plants Seed For New Company Direction
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm hopes the distribution deal for a tetanus diphtheria vaccine will pave the way for build-out of its vaccines and biologics business.
You may also be interested in...
Akorn Expands Commercialization Agreement With Indian Partner Natco
The specialty pharma adds a first-line advanced breast cancer treatment to the deal to commercialize two oral cancer generics.
Spectrum’s Iso-Vorin Could Clear FDA For Osteosarcoma By First Quarter
The Irvine, Calif., firm also plans sNDAs for a colorectal cancer claim and an oral formulation of the leucovorin relative.
Thelin's Third "Approvable" Letter Recommends Additional Clinical Trial
Encysive may be forced to make "significant reductions" to infrastructure and workforce, firm says June 15.